Literature DB >> 23314985

Diagnostic image quality of gadolinium-enhanced T1-weighted MRI with and without fat saturation in children with retinoblastoma.

Selma Sirin1, Marc Schlamann, Klaus A Metz, Norbert Bornfeld, Bernd Schweiger, Markus Holdt, Michael M Schuendeln, Simone Lohbeck, Andrej Krasny, Sophia L Goericke.   

Abstract

BACKGROUND: Gadolinium-enhanced T1-weighted MRI without fat saturation has been recommended for assessment of retinoblastoma.
OBJECTIVE: The purpose of this study was to compare diagnostic image quality without and with fat saturation following gadolinium administration.
MATERIALS AND METHODS: High-resolution gadolinium-enhanced T1-weighted sequences with and without fat saturation performed in children with subsequently histopathologically confirmed retinoblastoma were included. Image analysis (image quality [1 = poor, 2 = moderate, 3 = good], anatomical detail depiction, tumour extension) was performed by two neuroradiologists in consensus. Enhancement was scored and measured. Signal- and contrast-to-noise ratios were calculated. Image-assessed tumour invasiveness was compared to histopathological findings. Paired sample t-test was used for statistical analysis.
RESULTS: Thirty-six children (mean age, 19.0 ± 16.8 [SD] months) were included. Image quality and anatomical detail depiction were significantly better without fat saturation (P < 0.001). Tumour enhancement was rated higher with fat saturation (P < 0.001). Fat saturation improved detection of (post-)laminar optic nerve infiltration. Detection of choroidal invasion was improved without fat saturation. Combining both sequences was best in the assessment of tumour extension (sensitivity/specificity for (post-)laminar optic nerve infiltration, 75.0%/100.0%, and for choroidal invasion, 87.5%/85.7%).
CONCLUSION: Combined T1-weighted spin-echo imaging with and without fat saturation improved the image quality for assessment of invasiveness of retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314985     DOI: 10.1007/s00247-012-2576-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  24 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

2.  High-resolution MR imaging of the orbit in patients with retinoblastoma.

Authors:  Andreas M Rauschecker; Chirag V Patel; Kristen W Yeom; Christina A Eisenhut; Rakhee S Gawande; Joan M O'Brien; Katayoon B Ebrahimi; Heike E Daldrup-Link
Journal:  Radiographics       Date:  2012 Sep-Oct       Impact factor: 5.333

3.  Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.

Authors:  Shigenobu Suzuki; Takashi Yamane; Makoto Mohri; Akihiro Kaneko
Journal:  Ophthalmology       Date:  2011-06-29       Impact factor: 12.079

4.  Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.

Authors:  Swathi Kaliki; Carol L Shields; Sanket U Shah; Ralph C Eagle; Jerry A Shields; Ann Leahey
Journal:  Arch Ophthalmol       Date:  2011-11

5.  High resolution magnetic resonance imaging of retinoblastoma.

Authors:  A O Schueler; N Hosten; N E Bechrakis; A J Lemke; P Foerster; R Felix; M H Foerster; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

6.  Retinoblastoma: MR imaging parameters in detection of tumor extent.

Authors:  Pim de Graaf; Frederik Barkhof; Annette C Moll; Saskia M Imhof; Dirk L Knol; Paul van der Valk; Jonas A Castelijns
Journal:  Radiology       Date:  2005-02-04       Impact factor: 11.105

7.  Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.

Authors:  Carol L Shields; Melis Palamar; Pooja Sharma; Aparna Ramasubramanian; Ann Leahey; Anna T Meadows; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-03

8.  Treatment of retinoblastoma: current status and future perspectives.

Authors:  Carlos Rodriguez-Galindo; Guillermo L Chantada; Barrett G Haik; Matthew W Wilson
Journal:  Curr Treat Options Neurol       Date:  2007-07       Impact factor: 3.598

9.  Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.

Authors:  Carol L Shields; Aparna Ramasubramanian; Archana Thangappan; Kimberly Hartzell; Ann Leahey; Anna T Meadows; Jerry A Shields
Journal:  Ophthalmology       Date:  2009-01-20       Impact factor: 12.079

10.  Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.

Authors:  Matthew W Wilson; Carlos Rodriguez-Galindo; Catherine Billups; Barrett G Haik; Fred Laningham; Zoltan Patay
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

View more
  9 in total

1.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

2.  Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation.

Authors:  Hervé J Brisse; Pim de Graaf; Paolo Galluzzi; Kristel Cosker; Philippe Maeder; Sophia Göricke; Firazia Rodjan; Marcus C de Jong; Alexia Savignoni; Isabelle Aerts; Laurence Desjardins; Annette C Moll; Theodora Hadjistilianou; Paolo Toti; Paul van der Valk; Jonas A Castelijns; Xavier Sastre-Garau
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

3.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 2: new vs. old imaging concept.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-05-08       Impact factor: 2.804

4.  Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper.

Authors:  Felice D'Arco; Livja Mertiri; Pim de Graaf; Bert De Foer; Katarina S Popovič; Maria I Argyropoulou; Kshitij Mankad; Hervé J Brisse; Amy Juliano; Mariasavina Severino; Sofie Van Cauter; Mai-Lan Ho; Caroline D Robson; Ata Siddiqui; Steve Connor; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2022-04-23       Impact factor: 2.804

5.  MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma.

Authors:  Zhenzhen Li; Jian Guo; Xiaolin Xu; Wenbin Wei; Junfang Xian
Journal:  Br J Radiol       Date:  2021-12-03       Impact factor: 3.039

6.  Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis.

Authors:  Se Jin Cho; Jae Hyoung Kim; Sung Hyun Baik; Leonard Sunwoo; Yun Jung Bae; Byung Se Choi
Journal:  Neuroradiology       Date:  2020-08-31       Impact factor: 2.804

7.  [Retinoblastoma].

Authors:  N Bornfeld; D Lohmann; N E Bechrakis; E Biewald
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

8.  Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?

Authors:  Jesse L Berry; Emily Zolfaghari; Alexander Chen; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Ocul Oncol Pathol       Date:  2017-04-07

9.  Blood flow velocity in monocular retinoblastoma assessed by color Doppler.

Authors:  Maria Teresa B C Bonanomi; Osmar C Saito; Patricia Picciarelli de Lima; Roberta Chizzotti Bonanomi; Maria Cristina Chammas
Journal:  Clinics (Sao Paulo)       Date:  2015-12       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.